test

Alexandra Toohey

@Baker Bros. Advisors Lp

Latest period2024 - Q3ReportedManaged Assets$9.649BTotal holdings93
Assets growth rate23.31%Assets growth rate (2-Q avg)10.74%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Baker Bros. Advisors Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 93 positions.

Assets under management

The assets under management (AUM) of Baker Bros. Advisors Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 9.649B in assets, with a quarterly growth rate of 23.31% and a 2-quarter average growth rate of 10.74%. The portfolio is managed by Alexandra Toohey, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
CERSCerus Corporation
Recent Activity
0.36%
$33.891M
19.477M shares@ $1.75 avg price
IDYAIdeaya Biosciences, Inc.
Recent Activity
0.35%
$33.648M
1.062M shares@ $31.69 avg price
ROIVRoivant Sciences Ltd.
Recent Activity
0.34%
$32.297M
2.799M shares@ $11.55 avg price
AKROAkero Therapeutics, Inc.
Recent Activity
0.33%
$31.475M
1.097M shares@ $28.7 avg price
KRYSKrystal Biotech, Inc.
Recent Activity
0.33%
$30.933M
169,934 shares@ $182.03 avg price
CELCCelcuity Inc.
Recent Activity
0.29%
$27.956M
1.875M shares@ $14.92 avg price
GLUEMonte Rosa Therapeutics, Inc.
Recent Activity
0.28%
$26.055M
4.916M shares@ $5.31 avg price
DYNDyne Therapeutics, Inc.
Recent Activity
0.26%
$24.142M
672,096 shares@ $35.92 avg price
BMEABiomea Fusion, Inc.
Recent Activity
0.23%
$21.3M
2.109M shares@ $10.11 avg price
BCAXBicara Therapeutics Inc.
Recent Activity
New Position
0.22%
$21.225M
833,333 shares@ $25.48 avg price